Dr. Steffany Bennett is a lipid biochemist and systems neurobiologist working to identify gender and sex-specific differences in lipid metabolism associated with neurodegenerative disease. She is an expert in the use of high-performance liquid chromatography electrospray ionization tandem mass spectrometry as it is applied to neurolipidomics and to evidence-based personalized precision medicine.
She received her Ph.D. in Biochemistry from the University of Ottawa (Canada) and conducted post-doctoral training at the W. Alton Jones Cell Science Centre (USA), University of Rome “Tor Vergata” (Italy) and Harvard Medical School (USA). She is a Full Professor and University Research Chair in Neurolipidomics in the Department of Biochemistry, Microbiology, and Immunology and is cross-appointed to the Departments of Chemistry and Biomolecular Sciences as well as Cellular and Molecular Medicine.
As the Director of the Neural Regeneration Laboratory, she leads a research team dedicated to identifying the sex-, gender-and environmental-specific metabolic changes in lipids that predict vulnerability or resistance to devastating pediatric and geriatric neurodegenerative diseases. Her research seeks to modulate these changes to ensure healthy aging. These evidence- and gender-based methodological approaches inform her commitment to embedding the principles of equity, diversity, and inclusion into the scholarly and leadership environments of the University of Ottawa. Professor Bennett was recently appointed a Special Advisor to the President and will carry out her mandate as a subject-matter expert on equity, diversity, and inclusion for the University Community.